Company intelligence / Profile preview

N.W. Fulcher

Riverport, Nova Scotia, Canada

Ownership: Private
Development stage: Other

Overview

N.W. Fulcher is a private Canadian holding/investment company rather than an operating life sciences, biotech, pharma, or healthcare company. Publicly available references to the entity primarily appear in securities and early-warning filings related to investments in Nova Leap Health Corp. The company is owned and controlled by Wayne Fulcher. There is no evidence from the available sources that N.W. Fulcher develops therapeutics, operates a healthcare services business, or maintains a drug pipeline. It appears best characterized as an investment vehicle with exposure to a healthcare-related public company, not as a healthcare operating company.

Industry: Investors

Beyond the preview

Go deeper on N.W. Fulcher.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on N.W. Fulcher.

Explore the full profile